Clinical Trial: Exploring Clinical and Molecular Features Associated with Early Efficacy Heterogeneity of Ivarmacitinib in the Treatment of Atopic Dermatitis: A Prospective Cohort Study (China)

Posted On: 2026-09-28

China, Sept. 28 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Exploring Clinical and Molecular Features Associated with Early Efficacy Heterogeneity of Ivarmacitinib in the Treatment of Atopic Dermatitis: A Prospective Cohort Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133438

Registration Time: 2026/09/28

Type: Observational study

Primary Sponsor: The First Affiliated Hospital of Army Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=345302

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Exploring Clinical and Molecular Features Associated with Early Efficacy Heterogeneity of Ivarmacitinib in the Treatment of Atopic Dermatitis: A Prospective Cohort Study (China)